Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

XERS — Xeris Biopharma Holdings, Inc.

N/A · Quality 43/100

Value Score 30 days ago: 5.9 → today 6.3

XERS - Xeris Biopharma Holdings, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 16.52 USD
Intrinsic value: 4.75 USD
Margin of safety: -220.0%
Implied growth (reverse DCF): +20.6% (model assumes +5.5%)
Valuation: N/A
Value Score: 6.3
Quality: 43/100
Moat score: 40 (erosion: none)
N/A - Quality 43/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/XERS
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

16.52

Intrinsic value

4.75

Margin of safety

-220.0%

Implied growth (reverse DCF)

+20.6%

model assumes +5.5%

Value Score

6.3

Quality

Psychology

-185.6

Discovery

71.6

price/volume attention only

Moat score

erosion: none

Value Score: bottom 10% of Russell 3000 · Quality: bottom 30%

Open the interactive Deep Dive for XERS →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/XERS - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

What is Xeris Biopharma Holdings, Inc.'s Value Score?

Xeris Biopharma Holdings, Inc.'s Value Score is 6.3 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.